Edwards Lifesciences Corporation (EW) reported adjusted earnings per share (EPS) of 64 cents in fourth-quarter 2023, in line with the Zacks Consensus Estimate. The figure is also in line with the year-ago quarter’s level.The quarter’s one-time adjustments primarily include the spin-off of Critical care and the prior period’s ongoing tax.GAAP EPS were 61 cents in the quarter, down 6.2% year over year.For the full year, adjusted earnings were $2.30 per share, down 5.7% from the year-ago period’s levels. It al ...